On July 30, 2020, NMPA issued theOpinions on Reinforcing ADR Monitoring & Evaluation System and Capacity Building, in order to conscientiously implement the Drug Administration Law, Vaccine Administration Law, Regulations for the Supervision and Administration of Medical Devices and Regulations for the Supervision and Administration of Cosmetics, effectively reinforce the system and capacity building for monitoring&evaluation of adverse drug reactions, medical device adverse events, cosmetic adverse reactions, and drug abuse, continuously improve the monitoring&evaluation capacity, and comprehensively promote the safety of drugs, medical devices and cosmetics for public use to protect and promote public health.